| scholarly article | Q13442814 |
| P50 | author | Harvey Lodish | Q5677403 |
| Yoav Henis | Q67266402 | ||
| P2093 | author name string | H. F. Lodish | |
| M. D. O'Connor-McCourt | |||
| A. Moustakas | |||
| H. Y. Lin | |||
| J. Plamondon | |||
| P2860 | cites work | Molecular cloning and characterization of the human and porcine transforming growth factor-beta type III receptors | Q24337598 |
| TGF beta signals through a heteromeric protein kinase receptor complex | Q24337608 | ||
| Membrane-anchored and soluble forms of betaglycan, a polymorphic proteoglycan that binds transforming growth factor-beta | Q24679265 | ||
| Receptors for the TGF-β family | Q28210923 | ||
| Crystal structure of transforming growth factor-beta 2: an unusual fold for the superfamily | Q28284251 | ||
| An unusual feature revealed by the crystal structure at 2.2 A resolution of human transforming growth factor-beta 2 | Q28291529 | ||
| Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-beta receptor system | Q28304498 | ||
| Expression cloning and characterization of the TGF-beta type III receptor | Q28304515 | ||
| Cloning of a type I TGF-beta receptor and its effect on TGF-beta binding to the type II receptor | Q28507865 | ||
| The transforming growth factor-beta family | Q29615948 | ||
| Association of Sos Ras exchange protein with Grb2 is implicated in tyrosine kinase signal transduction and transformation | Q29616396 | ||
| Transforming growth factor-beta: recent progress and new challenges | Q35236115 | ||
| Distribution and modulation of the cellular receptor for transforming growth factor-beta | Q36217344 | ||
| Growth inhibition by transforming growth factor beta (TGF-beta) type I is restored in TGF-beta-resistant hepatoma cells after expression of TGF-beta receptor type II cDNA | Q36351854 | ||
| Molecular characterization of rat transforming growth factor-beta type II receptor | Q36770981 | ||
| Characterization of transforming growth factor-beta (TGF-beta) receptors on BeWo choriocarcinoma cells including the identification of a novel 38-kDa TGF-beta binding glycoprotein | Q37374932 | ||
| Glycolysis and methylaminoisobutyrate uptake in rat-1 cells transfected with ras or myc oncogenes | Q37689294 | ||
| TGF-beta receptors and TGF-beta binding proteoglycans: recent progress in identifying their functional properties | Q37886466 | ||
| Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase | Q41639273 | ||
| Structure and properties of the cellular receptor for transforming growth factor type beta | Q42811537 | ||
| Binding of transforming growth factor-beta to cell surface proteins varies with cell type | Q43778425 | ||
| The transforming growth factor-beta system, a complex pattern of cross-reactive ligands and receptors | Q43868753 | ||
| Transforming growth factors type beta 1 and beta 2 are equipotent growth inhibitors of human breast cancer cell lines. | Q53512451 | ||
| Isolation and characterization of mink lung epithelial cell mutants resistant to transforming growth factor beta. | Q53532164 | ||
| Role of receptor complexes in resistance or sensitivity to growth inhibition by TGF beta in intestinal epithelial cell clones. | Q54252636 | ||
| Subtypes of betaglycan and of type I and type II transforming growth factor‐β (TGF‐β) receptors with different affinities for TGF‐β1 and TGF‐β2 are exhibited by human placental trophoblast cells | Q67485868 | ||
| Absence of TGF-beta receptors and growth inhibitory responses in retinoblastoma cells | Q69915851 | ||
| A transforming growth factor beta (TGF-beta) receptor from human placenta exhibits a greater affinity for TGF-beta 2 than for TGF-beta 1 | Q70143376 | ||
| Transforming growth factor beta 1: secondary structure as determined by heteronuclear magnetic resonance spectroscopy | Q70540504 | ||
| Receptors for the TGF-beta superfamily: multiple polypeptides and serine/threonine kinases | Q75292788 | ||
| P433 | issue | 30 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 22215–22218 | |
| P577 | publication date | 1993-10-25 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | The transforming growth factor beta receptors types I, II, and III form hetero-oligomeric complexes in the presence of ligand | |
| P478 | volume | 268 |
| Q40019241 | A dominant inhibitory mutant of the type II transforming growth factor beta receptor in the malignant progression of a cutaneous T-cell lymphoma |
| Q35594463 | Associated changes of lipid peroxidation and transforming growth factor beta1 levels in human colon cancer during tumour progression. |
| Q35605733 | Beta3 integrin and Src facilitate transforming growth factor-beta mediated induction of epithelial-mesenchymal transition in mammary epithelial cells |
| Q24673586 | Betaglycan can act as a dual modulator of TGF-beta access to signaling receptors: mapping of ligand binding and GAG attachment sites |
| Q42982034 | Betaglycan has multiple binding sites for transforming growth factor-beta 1. |
| Q43783586 | Binding Properties of the Transforming Growth Factor-β Coreceptor Betaglycan: Proposed Mechanism for Potentiation of Receptor Complex Assembly and Signaling. |
| Q24548576 | Bone morphogenetic protein receptor complexes on the surface of live cells: a new oligomerization mode for serine/threonine kinase receptors |
| Q33294512 | Characterization of novel transforming growth factor-beta type I receptors found in malignant pleural effusion tumor cells |
| Q41337268 | Colon cancer cells that are not growth inhibited by TGF-beta lack functional type I and type II TGF-beta receptors |
| Q36857821 | Complexity in interpretation of embryonic epithelial-mesenchymal transition in response to transforming growth factor-beta signaling |
| Q33962863 | Defects of TGF-beta receptor signaling in mammary cell tumorigenesis |
| Q30436708 | Different domains regulate homomeric and heteromeric complex formation among type I and type II transforming growth factor-beta receptors |
| Q50298154 | Dimeric TGF-beta-1 binds to the receptor |
| Q47240245 | Dually modified transmembrane proteoglycans in development and disease |
| Q36236945 | Endoglin modulates cellular responses to TGF-beta 1. |
| Q39992153 | Expression and autoregulation of transforming growth factor beta receptor mRNA in small-cell lung cancer cell lines |
| Q37697197 | GS domain mutations that constitutively activate T beta R-I, the downstream signaling component in the TGF-beta receptor complex |
| Q36551569 | Independent changes in type I and type II receptors for transforming growth factor beta induced by bone morphogenetic protein 2 parallel expression of the osteoblast phenotype |
| Q92784010 | Integrin-Mediated TGFβ Activation Modulates the Tumour Microenvironment |
| Q41048740 | Ligand-dependent and -independent interactions with the transforming growth factor type II and I receptor subunits reside in the aminoterminal portion of the ectodomain of the type III subunit |
| Q42166815 | Lipid Peroxidation and Transforming Growth Factor-β1 Levels in Gastric Cancer at Pathologic Stages |
| Q36160563 | Loss of functional cell surface transforming growth factor beta (TGF-beta) type 1 receptor correlates with insensitivity to TGF-beta in chronic lymphocytic leukemia |
| Q35608635 | Mapping of the ligand binding domain of the transforming growth factor beta receptor type III by deletion mutagenesis |
| Q41101968 | Mechanism of TGFbeta receptor inhibition by FKBP12 |
| Q36943272 | Monocrotaline pyrrole induces Smad nuclear accumulation and altered signaling expression in human pulmonary arterial endothelial cells |
| Q36276659 | Oligomeric structure of type I and type II transforming growth factor beta receptors: homodimers form in the ER and persist at the plasma membrane |
| Q38874906 | Paracrine co-delivery of TGF-β and IL-2 using CD4-targeted nanoparticles for induction and maintenance of regulatory T cells |
| Q41901900 | Plasmin cleaves betaglycan and releases a 60 kDa transforming growth factor-beta complex from the cell surface |
| Q35618973 | Proliferation of mutators in A cell population |
| Q28360679 | Recombinant soluble betaglycan is a potent and isoform-selective transforming growth factor-beta neutralizing agent |
| Q37639003 | Reconstitution and transphosphorylation of TGF-beta receptor complexes |
| Q41193401 | Reconstitution of a pentameric complex of dimeric transforming growth factor beta ligand and a type I, II, III receptor in baculoviral-infected insect cells |
| Q42825804 | Regulation of fibroblast procollagen production. Transforming growth factor-beta 1 induces prostaglandin E2 but not procollagen synthesis via a pertussis toxin-sensitive G-protein |
| Q40357624 | Restoration of TGF-beta signalling reduces tumorigenicity in human lung cancer cells |
| Q38915720 | Signaling Receptors for TGF-β Family Members |
| Q35907449 | Signaling by chimeric erythropoietin-TGF-beta receptors: homodimerization of the cytoplasmic domain of the type I TGF-beta receptor and heterodimerization with the type II receptor are both required for intracellular signal transduction. |
| Q53450533 | TGF-beta in mammary development and neoplasia. |
| Q36235100 | TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors |
| Q45318132 | TGF-beta receptor signaling activates SMADs |
| Q90631766 | TGF-β Signaling |
| Q24297719 | TGF-β signalling is mediated by two autonomously functioning TβRI:TβRII pairs |
| Q50298155 | TGFBR2 recruits TGFBR1 |
| Q36843133 | TGFbeta induces SIK to negatively regulate type I receptor kinase signaling. |
| Q35135128 | The regulation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumor promotion by estradiol in female A/J mice |
| Q33630845 | The roles of TGFβ in the tumour microenvironment |
| Q42578955 | The type III TGF-β receptor betaglycan transmembrane-cytoplasmic domain fragment is stable after ectodomain cleavage and is a substrate of the intramembrane protease γ-secretase |
| Q36234419 | The types II and III transforming growth factor-beta receptors form homo-oligomers |
| Q36624210 | Transforming Growth Factor-beta2 protects the small intestine during methotrexate treatment in rats possibly by reducing stem cell cycling |
| Q24290737 | Type III TGF-beta receptor-independent signalling of TGF-beta2 via TbetaRII-B, an alternatively spliced TGF-beta type II receptor |
Search more.